| |
| |
|
| Insider
Information: |
Duggan Robert W |
| Relationship: |
Chief Executive Office... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
594,894,754 |
|
|
Indirect Shares
|
1,046,059 |
|
|
| Direct
Value |
$2,866,937,379 |
|
|
|
Indirect Value
|
$10,078,051 |
|
|
| Total
Shares |
595,940,813 |
|
|
| Total
Value |
$2,877,015,430 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
19
|
0
|
|
Stock
price went up :
|
5
|
0
|
| Stock
price went down : |
14
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -0.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intuitive Surgical Inc |
ISRG |
Director |
2011-05-18 |
1,000 |
2011-02-09 |
0 |
Premium* |
|
|
Pharmacyclics Inc |
PCYC |
Chairman and CEO, Dire... |
2015-05-26 |
0 |
2015-05-26 |
0 |
Premium* |
|
|
Pulse Biosciences, Inc. |
PLSE |
Director, 10% Owner |
2023-12-12 |
36,984,179 |
2023-12-12 |
843,634 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2019-03-20 |
5,555,414 |
2019-03-20 |
202,425 |
Premium* |
|
|
Summit Therapeutics Inc |
SMMT |
Chief Executive Office... |
2023-03-06 |
552,354,161 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
318 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 10 of 13
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ISRG |
Intuitive Surgical Inc |
Director |
– • – |
2006-05-10 |
4 |
S |
$129.05 |
$7,097,750 |
D/D |
(55,000) |
716,736 |
|
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2007-02-21 |
4 |
B |
$2.80 |
$172,800 |
I/I |
60,000 |
506,982 |
1.5 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-11-29 |
4 |
B |
$9.21 |
$552,600 |
I/I |
60,000 |
60,000 |
2.25 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-04-18 |
4 |
B |
$25.06 |
$1,576,025 |
D/D |
61,819 |
2,748,069 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-07-05 |
4 |
OE |
$2.14 |
$139,100 |
D/D |
65,000 |
36,162,824 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-04-06 |
4 |
B |
$18.54 |
$1,263,921 |
D/D |
65,400 |
2,452,886 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-05 |
4 |
B |
$9.34 |
$616,636 |
I/I |
66,021 |
351,565 |
2.25 |
% |
|
| ISRG |
Intuitive Surgical Inc |
Director |
– • – |
2005-08-26 |
4 |
S |
$71.92 |
$4,841,284 |
D/D |
(67,000) |
815,884 |
|
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-07-07 |
4 |
OE |
$2.14 |
$150,012 |
D/D |
67,133 |
36,229,957 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-08-03 |
4 |
B |
$23.70 |
$1,634,723 |
D/D |
68,964 |
3,387,694 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-03-16 |
4 |
B |
$22.54 |
$1,782,352 |
D/D |
73,782 |
2,247,141 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-07 |
4 |
B |
$9.19 |
$687,890 |
D/D |
74,852 |
36,759,406 |
3.92 |
% |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-09-05 |
4 |
B |
$2.47 |
$187,881 |
D/D |
76,065 |
5,074,564 |
3.92 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-04-25 |
4 |
B |
$13.02 |
$1,005,949 |
D/D |
77,247 |
7,028,153 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-11-27 |
4 |
B |
$1.68 |
$129,963 |
D/D |
77,585 |
8,421,530 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2018-11-23 |
4 |
B |
$1.89 |
$151,643 |
D/D |
80,175 |
8,343,945 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
officerTitle |
– – • |
2006-01-10 |
4 |
B |
$4.10 |
$335,980 |
I/I |
80,300 |
521,982 |
1.5 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
– • • |
2022-06-09 |
4 |
OE |
$0.00 |
$0 |
I/I |
81,025 |
411,044 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
– • • |
2023-06-14 |
4 |
OE |
$2.05 |
$166,101 |
I/I |
81,025 |
492,069 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-23 |
4 |
B |
$1.70 |
$139,431 |
D/D |
82,018 |
4,776,857 |
3.92 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-06 |
4 |
B |
$9.06 |
$750,286 |
D/D |
82,813 |
36,684,554 |
3.92 |
% |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-10-10 |
4 |
A |
$1.18 |
$100,000 |
D/D |
84,746 |
5,159,310 |
0 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
Director |
• • • |
2023-12-11 |
4 |
B |
$9.36 |
$843,504 |
D/D |
90,118 |
36,966,180 |
3.92 |
% |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-04-07 |
4 |
B |
$19.59 |
$1,843,795 |
D/D |
94,100 |
2,546,986 |
2.45 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2017-12-18 |
4 |
B |
$11.13 |
$1,057,493 |
D/D |
95,012 |
5,602,752 |
2.45 |
- |
|
318 Records found
|
|
Page 10 of 13 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
